Anesthesiology & Pain Medicine >> Research >> Institutional Review Board (IRB) Approval >> Updates & Announcements
Human Subjects IRB logo

Institutional Review Board (IRB)
Approval Information

Updates & Announcements

Current

Rescheduled HSD Information Sessions

HSD Director Karen Moe will be hosting informational sessions to learn about: eIRB, longer IRB approval periods, Human Subjects Assistants Program, marijuana research, and more!


Place Time Date
SLU, Orin Smith Auditorium 10:30 - 12:00 Monday, January 12
Harborview, R&T Auditorium 1:00 - 2:30 Tuesday, January 13
Kane Hall, Walker Ames Room 1:00 - 2:30 Wednesday, January 14
UW Bothell, UW2 Bldg, Rm 327
*new room*
10:30 - 12:00 Thursday, January 15
UW Tacoma, Research Commons, Rm 307b 12:30 - 2:00 Thursday, January 22
HSB, Turner Auditorium 2:30 - 4:00 Friday, January 23

Source: For the Record Monthly HSD Newsletter 1/5/15

Posted: 12/9/14

eIRB System: Zipline

HSD expects to deploy the new electronic application system (Zipline) in the 1st quarter of 2016.  Widespread beta testing and training will begin in autumn quarter.  The switch from a paper-based application system to an electronic system created the need and opportunity for a series of related and coordinated changes that will also occur during the next fourteen months:

  1. Forms and processes:  Application process will be simplified, primarily by reducing the number of forms and supplements.  Researchers will not need to make preliminary regulatory decisions, for example, whether an initial application qualifies for Minimal Risk review or must instead go to the full committee.
  2. Staff reorganization: The Full Board and Minimal Risk teams will be combined together.  The current 13 small teams will become 6 larger teams, each associated with one of the IRBs, and a new supervisory structure will be established.  Departments will still be assigned to specific teams, but this change will result in more flexible and consistent operations, staff with greater breadth and depth of expertise, and reduced integration and training time for new staff.

Posted: 1/14/15

Archived News

Boost the Visibility of Research Studies withRESEARCH PARTICPANT LINK

In collaboration with the UW School of Medicine, ITHS has developed a new site that offers researchers a centralized, coordinated resource to connect with potential study participants.

The registration process to post new research studies is free, open to any researcher with a UW NetID, and takes less than 10 minutes to complete.  You will be asked to enter:

  • Study information
  • Study team contacts
  • Institutional Review Board approval dates
  • Enrollment projections
  • Basic demographics

Once a study is approved to post, which usually occurs within one business day, the research team will be contacted directly by potential participants who visit Research Participant Link.

Please visit www.participateinresearch.org to learn more or to post a study.

Source:  ITHS e-mail 12/3/14

Posted: 12/10/14

Longer IRB Approval Periods

The new default IRB approval period will be 3 years instead of 1 year for studies that are:

  • Minimal risk
  • Not federally supported
  • Not regulated by the FDA

This new policy will be applied to all eligible new applications and Status Reports that are approved after 12/1/2014.

Resulting impact on researchers:

  • Estimated ~60% of minimal risk studies will be eligible for the longer approval periods

Source: For the Record Monthly HSD Newsletter 12/2/14

Posted: 12/9/14

IRB Performance Metrics

Median turn-around times:

  • Full IRB review: 59 days (n=86 applications)
  • Minimal risk review: 31 days (n=387 applications)
    • Use of Identifiable Specimens/Data: 17 days (n=114 applications)
  • Exempt Status: 5 days (n=266 applications)

Source: HSD Metrics Report #20 (reporting period 1/1/14 - 6/30/14)

Posted: 9/15/14

[to top]